Sponsor or institution
Clinical trials and research at Shenzhen Kangzhe Biotechnology Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Shenzhen Kangzhe Biotechnology Co., Ltd. that are recruiting, in China. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
CMS-D017 capsules: single and multiple dose testing in healthy adults
This trial will test CMS-D017 capsules in healthy Chinese adults to see if single and multiple oral doses are safe and how the drug behaves in the body.
-
CMS-D002 capsules for uterine fibroids with heavy menstrual bleeding
This test will see if taking a daily CMS-D002 capsule for 12 weeks reduces heavy menstrual bleeding in women aged 18–50 with uterine fibroids.
Quick answers
How many clinical trials run by Shenzhen Kangzhe Biotechnology Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.